2026-08-25 Psychedelics Today

Who Gets to Heal?

A donor gift with no diagnosis requirement forced a debate inside Thank You Life. Its executive director asks whether documented suffering should remain the price of admission to psychedelic care. The post Who Gets to Heal? appeared first on Psychedelics Today.

External link. We are not responsible for the content.

Read more ↗

More From Psychedelics Today

2026-08-25 Psychedelics Today

Weekly Psychedelic Policy Briefing: August 23, 2026

Oregon's psilocybin program posted its first real-world outcome data this week, just as regulators move on fee increa...

2026-08-19 Psychedelics Today

Horizons: Perspectives on Psychedelics

Please join us this autumn for the 19th Horizons conference on October 15-17 in New York City. This is one of the imp...

2026-08-18 Psychedelics Today

Weekly Psychedelic Policy Briefing – August 16, 2026

Resilient Pharmaceuticals has resubmitted its New Drug Application for MDMA-assisted therapy for PTSD, without the ne...

Latest News

2026-08-25 MAPS

University of Miami’s Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science

Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the ...

2026-08-24 The Microdose (Berkeley)

What’s stopping psychedelic therapy in China? 5 Questions with medical ethicist Jennifer Docherty

Docherty discusses her interviews about psychedelic end-of-life care with clinicians in Hong Kong.

2026-08-24 DoubleBlind Magazine

MDMA and the FDA, Take Two

PLUS the Psychedelic Seeker's Guide, the World Ayahuasca Forum, and the best films to get trippy to. [...] Read More....

2026-08-23 The Psychedelic Blog (Substack)

Global Altered States: Anytown, USA

This Week's Sunday Insider, Global Altered States: The Psychedelic Revolution is smaller than it looks.

2026-08-22 Lucid News

Psychedelic Policy Briefing 8.21.26

Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New ...

Research Policy
2026-08-21 The Microdose (Berkeley)

What is an “embedded” brain? Johnson & Johnson plans to invest in “neuroplastogen” company Delix; and University of Miami gifts Trump Administration accelerated path to research ibogaine

Plus: Oregon psilocybin program “generally safe,” according to new study, and New Mexico begins accepting psilocybin ...